The results also indicate that reducing the concentration of AGA in diabetes significantly decreases urinary nephrin and podocalyxin excretion, supporting the hypothesis that elevated concentrations of AGA in diabetes contribute to podocyte dysfunction. This evidence concerns the gene NPHS1 and diabetes mellitus.